129 related articles for article (PubMed ID: 22814014)
1. Comparison of the effects of valproic acid and levetiracetam on apoptosis in the human ovarian cancer cell line OVCAR-3.
Kwiecińska P; Taubøll E; Gregoraszczuk EL
Pharmacol Rep; 2012; 64(3):603-14. PubMed ID: 22814014
[TBL] [Abstract][Full Text] [Related]
2. Effects of valproic acid and levetiracetam on viability and cell cycle regulatory genes expression in the OVCAR-3 cell line.
Kwiecińska P; Taubøll E; Gregoraszczuk EL
Pharmacol Rep; 2012; 64(1):157-65. PubMed ID: 22580532
[TBL] [Abstract][Full Text] [Related]
3. Valproic acid, but not levetiracetam, selectively decreases HDAC7 and HDAC2 expression in human ovarian cancer cells.
Kwiecińska P; Wróbel A; Taubøll E; Gregoraszczuk EŁ
Toxicol Lett; 2014 Jan; 224(2):225-32. PubMed ID: 24200999
[TBL] [Abstract][Full Text] [Related]
4. Effects of valproic acid (VPA) and levetiracetam (LEV) on proliferation, apoptosis and hormone secretion of the human choriocarcinoma BeWo cell line.
Kwiecińska P; Wiśniewska J; Gregoraszczuk EŁ
Pharmacol Rep; 2011; 63(5):1195-202. PubMed ID: 22180362
[TBL] [Abstract][Full Text] [Related]
5. Effects of levetiracetam and valproate on reproductive endocrine function studied in human ovarian follicular cells.
Taubøll E; Gregoraszczuk EL; Wojtowicz AK; Milewicz T
Epilepsia; 2009 Aug; 50(8):1868-74. PubMed ID: 19490055
[TBL] [Abstract][Full Text] [Related]
6. Valproic Acid as a Promising Co-Treatment With Paclitaxel and Doxorubicin in Different Ovarian Carcinoma Cell Lines.
Kwiecińska P; Taubøll E; Grzyb E; Fiedor E; Ptak A; Gregoraszczuk EL
Int J Gynecol Cancer; 2016 Nov; 26(9):1546-1556. PubMed ID: 27654264
[TBL] [Abstract][Full Text] [Related]
7. Resting-state fMRI revealed different brain activities responding to valproic acid and levetiracetam in benign epilepsy with central-temporal spikes.
Zhang Q; Yang F; Hu Z; Zhang Z; Xu Q; Dante M; Wu H; Li Z; Li Q; Li K; Lu G
Eur Radiol; 2017 May; 27(5):2137-2145. PubMed ID: 27553940
[TBL] [Abstract][Full Text] [Related]
8. Levetiracetam but not valproate inhibits function of CD8+ T lymphocytes.
Li G; Nowak M; Bauer S; Schlegel K; Stei S; Allenhöfer L; Waschbisch A; Tackenberg B; Höllerhage M; Höglinger GU; Wegner S; Wang X; Oertel WH; Rosenow F; Hamer HM
Seizure; 2013 Jul; 22(6):462-6. PubMed ID: 23639870
[TBL] [Abstract][Full Text] [Related]
9. Comparison of reproductive effects of levetiracetam and valproate studied in prepubertal porcine ovarian follicular cells.
Taubøll E; Gregoraszczuk EL; Tworzydø A; Wójtowicz AK; Ropstad E
Epilepsia; 2006 Sep; 47(9):1580-3. PubMed ID: 16981877
[TBL] [Abstract][Full Text] [Related]
10. Direct and indirect comparison meta-analysis of levetiracetam versus phenytoin or valproate for convulsive status epilepticus.
Brigo F; Bragazzi N; Nardone R; Trinka E
Epilepsy Behav; 2016 Nov; 64(Pt A):110-115. PubMed ID: 27736657
[TBL] [Abstract][Full Text] [Related]
11. Levetiracetam, a new antiepileptic agent: lack of in vitro and in vivo pharmacokinetic interaction with valproic acid.
Coupez R; Nicolas JM; Browne TR
Epilepsia; 2003 Feb; 44(2):171-8. PubMed ID: 12558570
[TBL] [Abstract][Full Text] [Related]
12. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative and apoptotic effects of zinc-citrate compound (CIZAR(R)) on human epithelial ovarian cancer cell line, OVCAR-3.
Bae SN; Lee YS; Kim MY; Kim JD; Park LO
Gynecol Oncol; 2006 Oct; 103(1):127-36. PubMed ID: 16624386
[TBL] [Abstract][Full Text] [Related]
14. δ-Cadinene inhibits the growth of ovarian cancer cells via caspase-dependent apoptosis and cell cycle arrest.
Hui LM; Zhao GD; Zhao JJ
Int J Clin Exp Pathol; 2015; 8(6):6046-56. PubMed ID: 26261482
[TBL] [Abstract][Full Text] [Related]
15. Valproic Acid Promotes Apoptosis and Cisplatin Sensitivity Through Downregulation of H19 Noncoding RNA in Ovarian A2780 Cells.
Sajadpoor Z; Amini-Farsani Z; Teimori H; Shamsara M; Sangtarash MH; Ghasemi-Dehkordi P; Yadollahi F
Appl Biochem Biotechnol; 2018 Aug; 185(4):1132-1144. PubMed ID: 29468525
[TBL] [Abstract][Full Text] [Related]
16. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats.
van Vliet EA; Edelbroek PM; Gorter JA
Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045
[TBL] [Abstract][Full Text] [Related]
17. [Experimental study on the mechanism of the apoptosis of leukemic cells induced by valproic acid].
Xue HM; Li WY; Guo HX; Xia Y; Chen Q; Liu Y
Zhonghua Er Ke Za Zhi; 2005 Dec; 43(12):894-8. PubMed ID: 16412349
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of antiepileptic drugs on steroidogenesis in a human in vitro cell model.
Gustavsen MW; von Krogh K; Taubøll E; Zimmer KE; Dahl E; Olsaker I; Ropstad E; Verhaegen S
Acta Neurol Scand Suppl; 2009; (189):14-21. PubMed ID: 19566492
[TBL] [Abstract][Full Text] [Related]
19. Valproic acid, a histone deacetylase inhibitor, induces apoptosis in breast cancer stem cells.
Aztopal N; Erkisa M; Erturk E; Ulukaya E; Tokullugil AH; Ari F
Chem Biol Interact; 2018 Jan; 280():51-58. PubMed ID: 29225137
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of chronic administration of levetiracetam in a rat model of diabetic neuropathy.
Erbaş O; Oltulu F; Yılmaz M; Yavaşoğlu A; Taşkıran D
Diabetes Res Clin Pract; 2016 Apr; 114():106-16. PubMed ID: 26795972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
